(Q52844350)

8 May 2018

title

Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees. (English)

1 reference

8 May 2018

1 reference

7

1 reference

8 May 2018

Julia L. Hurwitz

8

object named as

J L Hurwitz

1 reference

8 May 2018

author name string

T D Lockey

1

1 reference

8 May 2018

K S Slobod

2

1 reference

8 May 2018

T E Caver

3

1 reference

8 May 2018

S D'Costa

4

1 reference

8 May 2018

R J Owens

5

1 reference

8 May 2018

H M McClure

6

1 reference

8 May 2018

publication date

1 January 2000

1 reference

8 May 2018

published in

Immunologic Research

1 reference

8 May 2018

volume

21

1 reference

8 May 2018

issue

1

1 reference

8 May 2018

page(s)

7-21

1 reference

8 May 2018

https://scigraph.springernature.com/pub.10.1385/ir:21:1:7

exact match

0 references

cites work

Fluctuating diversity in the HTLV-IIIB virus stock: implications for neutralization and challenge experiments

1 reference

12 December 2020

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

1 reference

12 December 2020

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

12 December 2020

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

12 December 2020

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group

1 reference

12 December 2020

Does envelope V3 peptide comprise the principal neutralizing determinant for HIV?

1 reference

12 December 2020

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

12 December 2020

Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

12 December 2020

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

1 reference

12 December 2020

Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection

1 reference

12 December 2020

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain

1 reference

12 December 2020

HIV vaccines. Magic of the occult?

1 reference

12 December 2020

Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes.

1 reference

12 December 2020

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1 reference

12 December 2020

HIV type 1 envelope sequence diversity in inner city community

1 reference

12 December 2020

A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.

1 reference

12 December 2020

Smallpox vaccination of eczema patients with a strain of attenuated live vaccinia (CVI-78)

1 reference

12 December 2020

Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1

1 reference

12 December 2020

Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody

1 reference

12 December 2020

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys

1 reference

12 December 2020

Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary subcutaneous vaccination

1 reference

12 December 2020

Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.

1 reference

12 December 2020

Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Basic study and laboratory standardization

1 reference

12 December 2020

Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain

1 reference

12 December 2020

A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation

1 reference

12 December 2020

Size-heterogeneous sequences mark hot spots for asparagine, serine, and threonine insertions in HIV type 1 envelope

1 reference

12 December 2020

Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants

1 reference

12 December 2020

Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120

1 reference

12 December 2020

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

12 December 2020

Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

1 reference

12 December 2020

Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus

1 reference

12 December 2020

Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group

1 reference

12 December 2020

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

12 December 2020

A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades.

1 reference

12 December 2020

Drift from the GPGRAF HIV-1 envelope V3 crown sequence in a North American inner city

1 reference

12 December 2020

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

12 December 2020

Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120.

1 reference

12 December 2020

Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual

1 reference

12 December 2020

Effect of natural HIV-1 envelope V1-V2 sequence diversity on the binding of V3-specific and non-V3-specific antibodies

1 reference

12 December 2020

Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers

1 reference

12 December 2020

Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus

1 reference

12 December 2020

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

1 reference

12 December 2020

Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals?

1 reference

12 December 2020

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

12 December 2020

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

12 December 2020

Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus

1 reference

12 December 2020

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

12 December 2020

Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

12 December 2020

Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting

1 reference

12 December 2020

Z-track injections. A step-by-step how-to for an underused IM technique

1 reference

12 December 2020

A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection

1 reference

12 December 2020

Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization

1 reference

12 December 2020

Back to primary school

1 reference

12 December 2020

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

1 reference

12 December 2020

Envelope Sequence Variation, Neutralizing Antibodies, and Primate Lentivirus Persistence

1 reference

12 December 2020

Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies.

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:21:1:7

1 reference

8 May 2018

Dimensions Publication ID

1000945836

0 references

Fatcat ID

release_msbfigx4gbcgjfttzda4xim6du

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/msbfigx4gbcgjfttzda4xim6du

24 November 2022

mapped directly with Wikidata item

1 reference

8 May 2018